Related Experiment Video
Updated: Mar 24, 2026

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
8.6K
Infant metabolic screening: a total quality management approach
1Memorial Regional Hospital, Hollywood, FL, USA.
Summary
Total Quality Management (TQM) improved infant metabolic screening by addressing specimen quality and delivery delays. This quality improvement initiative led to significant enhancements in screening program performance.
Area of Science:
- Healthcare Management
- Public Health
- Pediatrics
Background:
- Infant metabolic screening programs are crucial for early detection of genetic disorders.
- Challenges in specimen quality, delivery timeliness, and data accuracy can impede program effectiveness.
- Total Quality Management (TQM) offers a framework for systematic process improvement.
Purpose of the Study:
- To enhance the quality and efficiency of an urban hospital's infant metabolic screening program.
- To identify and rectify key issues affecting screening indicators.
- To evaluate the long-term impact of quality improvement interventions.
Main Methods:
- Application of Total Quality Management (TQM) principles.
- Formation of a multidisciplinary team to analyze and address quality issues.
- Implementation of targeted remedies for identified root causes.
- Continuous monitoring of key performance indicators over a 4-month implementation and 3-year evaluation period.
Main Results:
- Significant improvements were observed in specimen quality.
- Timeliness of specimen delivery to the state laboratory was dramatically enhanced.
- Reduction in instances of missing collection dates on specimen slips.
- Sustained improvements in all three key quality indicators over the evaluation period.
Conclusions:
- A multidisciplinary approach using TQM principles effectively improved infant metabolic screening.
- Quality improvement initiatives yield benefits for patients, healthcare staff, and potentially reduce costs.
- Sustained focus on quality management is essential for optimal public health program outcomes.
Related Concept Videos
Automated Microbial Diagnostics
11
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
11
Therapeutic Drug Monitoring: Overview and Classification
506
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
506
Therapeutic Drug Monitoring: Affecting Factors
323
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
323
Therapeutic Drug Monitoring: Drug Analysis Methods
282
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
282
Pharmacokinetics in Pediatric Patients: Drug Metabolism
322
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Inborn Errors of Metabolism
998
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
998

